Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience-Reference-Cited by-同舟云学术

Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

Published:2019-06-07 Issue:8 Volume:8 Page:3846-3854
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bertoli Sarah¹²³,Tavitian Suzanne¹,Bories Pierre⁴,Luquet Isabelle⁵,Delabesse Eric²³⁵,Comont Thibault⁶^ORCID,Sarry Audrey¹,Huguet Françoise¹,Bérard Emilie⁷⁸,Récher Christian¹²³^ORCID

Affiliation:

1. Service d'Hématologie Centre Hospitalier Universitaire de Toulouse Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France

2. Université Toulouse III Paul Sabatier Toulouse France

3. Cancer Research Center of Toulouse UMR1037‐INSERM, ERL5294 CNRS Toulouse France

4. Réseau Onco‐occitanie Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France

5. Laboratoire d'Hématologie Centre Hospitalier Universitaire de Toulouse Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France

6. Service de Médecine Interne Centre Hospitalier Universitaire de Toulouse Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France

7. Service d'Epidémiologie Centre Hospitalier Universitaire de Toulouse Toulouse France

8. UMR 1027 INSERM‐Université de Toulouse III Toulouse France

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2020

Reference29 articles.

1. Acute Myeloid Leukemia

2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

3. Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

4. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study

5. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt;Cancer;2024-01-20

2. Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry;Haematologica;2023-05-18

3. Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia;Cancers;2023-01-05

4. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML;Blood Advances;2022-08-29

5. Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia;Stem Cells Translational Medicine;2022-04-19